Tushar Pandey: Hounoured to Be Part of Hematocon 2025
Tushar Pandey, Editorial Board Member at Journal of Cancer Chemotherapy, shared on LinkedIn:
”HONOURED TO BE PART OF HEMATOCON 2025
Grateful for the opportunity to represent HALDWANI, UTTARAKHAND and the RAGHAV INSTITUTE OF HEMATOLOGY, HEMATO-ONCOLOGY and BONE MARROW TRANSPLANT (RIHOB) as FACULTY at the National Hematology Conference — Hematocon 2025.
Participated in a deeply insightful session on “INFECTIONS IN BONE MARROW TRANSPLANT AND NEUTROPENIC SETTINGS AND THEIR MANAGEMENT,” an area that remains vital to improving outcomes and safety in hematology and transplant care.
It was a privilege to share thoughts and exchange ideas with distinguished HEMATOLOGISTS — DR. Faheema Hasan , DR. ADITYA JANDIAL, DR. POORVI KAPOOR, AND DR. SAYAN ROY.
The discussion brought forward valuable perspectives on managing complex infections in immunocompromised patients.
Looking forward to continuing our collective efforts to strengthen hematology and transplant services across UTTARAKHAND AND NORTH INDIA.
Committed to advancing excellence in Hematology, Oncology and BMT care.”
Stay updated with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology